PT  - JOURNAL ARTICLE
AU  - Davis, Susan M.
TI  - IS THE INVERSE ASSOCIATION BETWEEN PARKINSON’S DISEASE AND SMOKING DUE TO CONFOUNDING?
AID  - 10.1101/2020.09.20.20198390
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.20.20198390
4099  - http://medrxiv.org/content/early/2020/09/23/2020.09.20.20198390.short
4100  - http://medrxiv.org/content/early/2020/09/23/2020.09.20.20198390.full
AB  - Parkinson’s disease (PD) is inversely associated with smoking. Whether this association is due to a causal relationship or to confounding by a covariate of smoking is still debated.This study included populations of the United States and ten U.S. states from 2004 to 2016. The ten U.S. states included the five states with the highest PD incidence rates in 2017 (Vermont, Maine, Kansas, Missouri, Colorado) and the five states with the lowest PD incidence rates in 2017 (Arkansas, Mississippi, South Dakota, Nebraska, Alabama). The study used scatter plots to explore the association between PD incidence and smoking and the association between PD incidence and a covariate of smoking, lower endoscopy utilization.The results indicate that there is a weaker association between PD and smoking when compared to the association between PD and lower endoscopy utilization. For PD incidence verses current smoking, the coefficient of determination (R2) for the United States was 0.813 and ranged from a low of 0.000 for Arkansas to 0.798 for Colorado (average R2 for the ten states was 0.391). For PD incidence verses lower endoscopy utilization, the R2 for the United States was 0.995 and ranged from a low of 0.871 for South Dakota to 0.997 for Colorado (average R2 for the ten states was 0.959).The results suggest that the inverse association between PD incidence and smoking is confounded by the direct association between PD and lower endoscopy utilization. Further investigation of a possible relationship between PD incidence and lower endoscopy utilization is warranted.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No approval needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesParkinson's disease incidence data is available from the Institute for Health Metrics and Evaluation (IHME)'s Global Burden of Diseases, Injuries, and Risk Factors (GBD) Compare visualization system (available at https://vizhub.healthdata.org/gbd-compare). Current smoking and endoscopy usage data are available from the Centers for Disease Control and Prevention (CDC)'s Behavioral Risk Factor Surveillance System (BRFSS) Web Enabled Analysis Tool (WEAT) (available at https://www.cdc.gov/brfss/data_tools.htm). https://vizhub.healthdata.org/gbd-compare https://www.cdc.gov/brfss/data_tools.htm